about
Influence of Size and Shape on the Anatomical Distribution of Endotoxin-Free Gold Nanoparticles.Uptake and intracellular fate of disulfide-bonded polymer hydrogel capsules for Doxorubicin delivery to colorectal cancer cells.Shape-dependent cellular processing of polyelectrolyte capsules.Characterization of novel splice variants of LGR7 and LGR8 reveals that receptor signaling is mediated by their unique low density lipoprotein class A modules.Engineering multifunctional capsules through the assembly of metal-phenolic networks.CD14(hi)CD16+ monocytes phagocytose antibody-opsonised Plasmodium falciparum infected erythrocytes more efficiently than other monocyte subsets, and require CD16 and complement to do soDifferential Responses of Pattern Recognition Receptors to Outer Membrane Vesicles of Three Periodontal PathogensThe role of particle geometry and mechanics in the biological domain.Emerging techniques in proteomics for probing nano-bio interactions.Engineering and evaluating drug delivery particles in microfluidic devices.Interfacing materials science and biology for drug carrier design.Role of the Protein Corona Derived from Human Plasma in Cellular Interactions between Nanoporous Human Serum Albumin Particles and Endothelial Cells.In vivo imaging and tracking of individual nanodiamonds in drosophila melanogaster embryos.Analysing intracellular deformation of polymer capsules using structured illumination microscopy.Shape-Dependent Activation of Cytokine Secretion by Polymer Capsules in Human Monocyte-Derived Macrophages.Redox-Sensitive PEG-Polypeptide Nanoporous Particles for Survivin Silencing in Prostate Cancer Cells.Unravelling "off-target" effects of redox-active polymers and polymer multilayered capsules in prostate cancer cells.Physicochemical and immunological assessment of engineered pure protein particles with different redox states.Engineering poly(ethylene glycol) particles for improved biodistribution.Monoclonal antibody-functionalized multilayered particles: targeting cancer cells in the presence of protein coronas.The "sweet" side of the protein corona: effects of glycosylation on nanoparticle-cell interactions.Differential roles of the protein corona in the cellular uptake of nanoporous polymer particles by monocyte and macrophage cell lines.Immunological Principles Guiding the Rational Design of Particles for Vaccine Delivery.Particle carriers for combating multidrug-resistant cancer.Macromolecule functionalization of disulfide-bonded polymer hydrogel capsules and cancer cell targeting.Bypassing multidrug resistance in cancer cells with biodegradable polymer capsules.Encapsulation of water-insoluble drugs in polymer capsules prepared using mesoporous silica templates for intracellular drug delivery.Toward therapeutic delivery with layer-by-layer engineered particles.Low-fouling poly(N-vinyl pyrrolidone) capsules with engineered degradable properties.Identification of the N-linked glycosylation sites of the human relaxin receptor and effect of glycosylation on receptor function.Identification of Receptor Binding to the Biomolecular Corona of Nanoparticles.Studies on soluble ectodomain proteins of relaxin (LGR7) and insulin 3 (LGR8) receptors.The role of capsule stiffness on cellular processing.Biodegradable click capsules with engineered drug-loaded multilayers.Particles on the move: intracellular trafficking and asymmetric mitotic partitioning of nanoporous polymer particles.Cell-Conditioned Protein Coronas on Engineered Particles Influence Immune Responses.Engineering fluorescent poly(dopamine) capsules.Quantum measurement and orientation tracking of fluorescent nanodiamonds inside living cells.Differential Recognition of Nanoparticle Protein Corona and Modified Low-Density Lipoprotein by Macrophage Receptor with Collagenous Structure.Self-Polymerization of Dopamine as a Versatile and Robust Technique to Prepare Polymer Capsules
P50
Q30101052-BCA50CA6-A4E0-4D0F-9183-0B346D3C0F35Q33564802-41C8060E-E662-48D7-ADD6-98563F80454FQ34317178-1F9C173F-5ED9-4BB5-9B11-9CBB1DA39BB6Q34564974-F4D5D139-5DAD-4CA4-9EAC-86FC3E31892CQ35139336-A1E5DC2E-53B7-481C-8B48-658C5F67B909Q35684739-D580DF6D-3981-4155-BE40-558A8C374289Q35976366-46128025-14A9-47DA-9159-8019E93ED5F6Q38062890-3F39C042-773F-46C0-8553-2DB7354FB9D4Q38065181-AAAAE546-5D00-48AD-8859-E691FA068CEBQ38209260-5E3B6C98-F364-4FE9-B20A-20C8B7504921Q38366527-EEC11B42-7A99-44F0-8CA0-5318DE692BCBQ38712089-6018E8D0-0341-4950-AF41-19B187107265Q38741236-417CEF5F-72B3-47DF-AD98-B0BE6F84061AQ38767449-0A28BD50-1902-47C2-8EF4-811BF8EDDEDBQ38790752-BFB8B280-2095-4819-AC42-3F4FCCBE3294Q38859104-A691E943-EA00-42F3-AD32-AA106AEDA4C4Q38898652-84356FF1-4C07-4A58-9769-22D0923A1E46Q38906139-AF45EE56-98E9-4C64-A720-FB00817EB908Q38906318-88DE5C5A-D7D0-4B04-90FF-7208CBFBDE8AQ38906458-183316FA-2AB7-41C8-BD63-1108830EC255Q38918844-D826C73F-9DF0-4197-8351-E52A0E59CFEFQ39060798-82CB0287-D019-42F3-8C7F-81183528F0BFQ39079574-409C528E-0505-47B1-A140-A0E4933032C6Q39317767-104C73AF-3C15-4176-BEA8-CCD70BC30A5EQ39409838-F0637505-75E8-4464-8DA0-D063DAF8444FQ39639787-C5F6C137-7891-4E8D-AB02-DA1B4B933C49Q39690268-6992A548-DE7D-403C-8671-1F7D7EDDCE7EQ39746705-5B74B97F-A5AD-40BC-853E-F3CDCC2BB1F6Q39806097-C714782B-5A94-489E-B285-8E9914EAF720Q39974895-3912BB15-4E35-4D9D-A16E-84985F98A404Q40361896-812C586F-C80F-4608-B47B-B7F86678C3F8Q40409551-50068268-5915-4E58-A144-1CDA7A689ADDQ40989920-F6BDC54C-19FA-4D09-B1D9-F3741A84BD3DQ43726535-137C17F9-7E3B-434F-B79D-95237BB5D9EAQ44958679-9C878307-3605-4A38-8770-B8A5756947ACQ48364319-E0A424C3-1193-43FD-992A-EB0C837652EAQ48748563-E2A3B744-3C76-44EB-ABB4-3717071F9439Q50681951-1AA3B20A-DAB6-4C33-A547-A82C0571A93FQ52318005-82A58B40-A0D9-4D73-ADA0-3F530134B10AQ56769284-6569D925-28C2-46AA-8684-951DF2684C97
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Yan Yan
@ast
Yan Yan
@en
Yan Yan
@es
Yan Yan
@sl
type
label
Yan Yan
@ast
Yan Yan
@en
Yan Yan
@es
Yan Yan
@sl
prefLabel
Yan Yan
@ast
Yan Yan
@en
Yan Yan
@es
Yan Yan
@sl
P1053
A-3720-2009
P106
P21
P31
P3829
P496
0000-0003-2938-4063
P569
2000-01-01T00:00:00Z